Upsher-Smith Announces Manufacturing, Supply and Distribution Agreement with Sandoz
Maple Grove, MN – June 3, 2014 – Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system, today announced that it has entered into a potassium chloride manufacturing, supply and distribution agreement with Princeton-based Sandoz Inc. This agreement is part of Upsher-Smith's strategy to maximize the distribution and sales of its potassium chloride products.
Specific terms related to the deal have not been disclosed.
Upsher-Smith Laboratories, Inc., founded in 1919, is a growing pharmaceutical company dedicated to its mission of Advancing Pharmacotherapy. Improving Life™. With capabilities ranging from early-stage research to delivering on-market products, Upsher-Smith is committed to offering quality products that enable people to live life to its greatest potential. Upsher-Smith's approach to product development and partnering has resulted in a robust pipeline of promising CNS therapies in various stages of development. For more information, visit www.upsher-smith.com.
Client Operations Specialist
23 Hubbard Road
Wilton, Connecticut 06897
p: 203.762.8833 fx: 203.762.9195
e-mail: [email protected]